Translating science into medicine, Celerion is a premier, global provider of early clinical research. We recognize that access to experts and regulatory guidance at the appropriate times of your vaccine development plan are critical for your success. We have the experience and expertise to assist with these discussions and provide guidance into crucial early clinical development as well as pivotal efficacy and safety studies. Celerion’s expertise spans a large variety of vaccines within Infectious Diseases, Oncology, and Autoimmune Diseases. Our experience includes both preventive and therapeutic vaccines across all phases and many different routes of administration, and patient populations.